Glaxo cuts HIV drug cost for developing world.
D019380:Anti-HIV Agents / Q000191:economics*; D003365:Costs and Cost Analysis; D003906:Developing Countries; D004345:Drug Industry / Q000191:economics*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000635:transmission; D006801:Humans; D018445:Infectious Disease Transmission, Vertical; D019259:Lamivudine / Q000191:economics / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D018894:Reverse Transcriptase Inhibitors / Q000191:economics / Q000627:therapeutic use; D015215:Zidovudine / Q000191:economics / Q000627:therapeutic use
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D015215:Zidovudine